Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06086795 · ClinicalTrials.gov registry record · NA
Investigating Age-dependent Effects of Egg Intake on HDL and Immune Profiles
A NA study of Inflammatory Response and Lipoproteins, sponsored by University of Connecticut.
- Active
- Registry status
- NA
- Development phase
- 46
- Enrollment target
- 1
- Study location
NCT06086795: Active NA study of Inflammatory Response and Lipoproteins, sponsored by University of Connecticut.
NCT06086795 is a NA study of Inflammatory Response and Lipoproteins that is active but no longer recruiting, run by University of Connecticut. The registered enrollment target is 46 participants, below the 175-participant average among 16 other Inflammatory Response trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06086795, a NA study of Inflammatory Response and Lipoproteins, is active but no longer recruiting, sponsored by University of Connecticut.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this intervention study is to determine whether consumption of different fractions of chicken eggs, including egg whites, egg yolks, and whole eggs, confer different changes in markers of HDL function and T cell profiles in younger vs. older men and women. The study will address the following objectives: * Objective 1: Determine if daily consumption of egg fractions differentially alter HDL profiles across age groups. * Objective 2: Determine if daily consumption of egg fractions differentially alter immune cell profiles across age groups. Participants will be asked to consume egg whites, egg yolks, and whole eggs on a daily basis for 4-weeks each, and avoid eating eggs for a total of 8 weeks at different points in the study. Participants will additionally be provided guidance on following a generally healthy diet, and will be asked to complete surveys about dietary intake and physical activity, as well as provide blood samples throughout the course of the study. Researchers will compare whether daily consumption of egg whites, egg yolks, and whole eggs differentially alter markers of HDL function and T cell profiles in younger vs. older adults.
Primary Outcome
Measurement of serum large HDL particles (nmol/L) at the egg-free run-in period and the end of each intervention arm.
Conditions Studied
Interventions
- OTHER Whole eggs
- OTHER Egg yolks
- OTHER Egg whites
Study Locations (1)
Connecticut
- University of Connecticut - Storrs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2024-01-23 |
| Est. Completion | 2026-06 |
| Phase | NA |
What the registry record for NCT06086795 still lists
NCT06086795 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 175-participant average among 16 other Inflammatory Response trials with a reported enrollment target (74% lower).
The record links to 2 conditions, with Inflammatory Response appearing as the primary indexed condition, and to 3 interventions - of which Whole eggs is the first listed.
NCT06086795 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT06086795 about?
NCT06086795 is a clinical study titled "Investigating Age-dependent Effects of Egg Intake on HDL and Immune Profiles". The goal of this intervention study is to determine whether consumption of different fractions of chicken eggs, including egg whites, egg yolks, and whole eggs, confer different changes in markers of HDL function and T cell profiles in younger vs. older men and women. The study will address the foll...
What is the current status of trial NCT06086795?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 46 participants. The study started on 2024-01-23. Estimated completion is 2026-06.
What conditions does trial NCT06086795 study?
This clinical trial studies the following conditions: Inflammatory Response, Lipoproteins.
What interventions are being tested in trial NCT06086795?
The interventions under investigation include: Whole eggs (OTHER), Egg yolks (OTHER), Egg whites (OTHER).
Who is sponsoring clinical trial NCT06086795?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06086795 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammatory Response
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06086795's enrollment target sits among peer trials
46 10th of 16 higher than 7 of 16 other Inflammatory Response trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Inflammatory Response trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Menthol, Inflammation, and Nicotine Transition Study
RECRUITING · NA
-
Examining the Role of Female Endogenous Sex Hormones in Eccentric Exercise
RECRUITING · NA
-
Association Between Body Composition and Pain in Spinal Cord Injury
RECRUITING · NA
-
Social Experiences and Demographic Factors in the Regulation of Immune Cells
RECRUITING · NA
-
Daoist Zhanzhuang and Human Flourishing
RECRUITING · NA
-
Beef and Plant Burger Metabolomics Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI